Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351–8.

Article  PubMed  PubMed Central  Google Scholar 

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41 – 7.

Sharpless JL. Polycystic ovary syndrome and the metabolic syndrome. Clinical Diabetes. 2003;21(4):154–61.

Article  Google Scholar 

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–79.

Article  PubMed  PubMed Central  Google Scholar 

Li HW, Lam KS, Tam S, Lee VC, Yeung TW, Cheung PT, et al. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome. Hum Reprod. 2015;30(9):2178–83.

Article  CAS  PubMed  Google Scholar 

Oleniuc M, Schiller A, Secara I, Onofriescu M, Hogas S, Apetrii M, et al. Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients. Int Urol Nephrol. 2012;44(5):1441–9.

Article  CAS  PubMed  Google Scholar 

de Groot L, Hinkema H, Westra J, Smit AJ, Kallenberg CG, Bijl M, et al. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther. 2011;13(6):R205.

Article  PubMed  PubMed Central  Google Scholar 

Schröter D, Höhn A. Role of Advanced Glycation End Products in Carcinogenesis and their therapeutic implications. Curr Pharm Des. 2018;24(44):5245–51.

Article  PubMed  Google Scholar 

Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The role of Advanced Glycation End Products in Aging and metabolic Diseases: Bridging Association and Causality. Cell Metab. 2018;28(3):337–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang B, Hao M, Yang Q, Li J, Guo Y. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet. 2016;33(7):959–65.

Article  PubMed  PubMed Central  Google Scholar 

de Vos LC, Lefrandt JD, Dullaart RP, Zeebregts CJ, Smit AJ. Advanced glycation end products: an emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis. 2016;254:291–9.

Article  PubMed  Google Scholar 

Ruiz HH, Ramasamy R, Schmidt AM. Advanced Glycation End Products: building on the Concept of the “Common Soil” in metabolic disease. Endocrinology. 2020;161(1).

Wu F, Afanasyeva Y, Zeleniuch-Jacquotte A, Zhang J, Schmidt AM, Chen Y. Temporal reliability of serum soluble and endogenous secretory receptors for advanced glycation end-products (sRAGE and esRAGE) in healthy women. Cancer Causes Control. 2018;29(10):901–5.

Article  PubMed  PubMed Central  Google Scholar 

Juranek JK, Daffu GK, Geddis MS, Li H, Rosario R, Kaplan BJ, et al. Soluble RAGE treatment delays progression of amyotrophic lateral sclerosis in SOD1 mice. Front Cell Neurosci. 2016;10:117.

Article  PubMed  PubMed Central  Google Scholar 

Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2005;62(1):37–43.

Article  CAS  PubMed  Google Scholar 

Garg D, Merhi Z. Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS. Reprod Biol Endocrinol. 2016;14(1):71.

Article  PubMed  PubMed Central  Google Scholar 

Merhi Z. Advanced glycation end products and their relevance in female reproduction. Human Reproduction. 2013;29(1):135–45.

Article  PubMed  Google Scholar 

Kalea AZ, Schmidt AM, Hudson BI. RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond). 2009;116(8):621–37.

Article  CAS  PubMed  Google Scholar 

Andersen M, Glintborg D. Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT? Eur J Endocrinol. 2018;179(3):D1-d14.

Article  PubMed  Google Scholar 

Wong HYQ, Li HWR, Lam KSL, Tam S, Shek CC, Lee CYV, et al. Independent association of serum vitamin D with anti-mullerian hormone levels in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018;89(5):634–41.

Article  CAS  PubMed  Google Scholar 

Chen LH, Heng Mak TS, Fan Y, Yin Ho DT, Sham PC, Chu LW, et al. Associations between CLU polymorphisms and memory performance: the role of serum lipids in Alzheimer’s disease. J Psychiatr Res. 2020;129:281–8.

Article  PubMed  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

Article  CAS  PubMed  Google Scholar 

Association AD. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;40(Supplement_1):S11-S24.

Google Scholar 

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.

Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339–52.

Article  CAS  PubMed  Google Scholar 

Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol. 2010;25(6):375–84.

Article  PubMed  Google Scholar 

Morgan CL, Currie CJ, Peters JR. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000;23(8):1103–7.

Article  CAS  PubMed  Google Scholar 

Herman WH, Ye W, Griffin SJ, Simmons RK, Davies MJ, Khunti K, et al. Early detection and treatment of type 2 diabetes reduce Cardiovascular Morbidity and Mortality: A Simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–55.

Article  PubMed  PubMed Central  Google Scholar 

Perrone A, Giovino A, Benny J, Martinelli F. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxid Med Cell Longev. 2020;2020:3818196.

Article  PubMed  PubMed Central  Google Scholar 

Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911 – 16.e12.

Article  PubMed  PubMed Central  Google Scholar 

Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes. 2002;51(11):3274–82.

Article  CAS  PubMed  Google Scholar 

He CT, Lee CH, Hsieh CH, Hsiao FC, Kuo P, Chu NF, et al. Soluble form of receptor for advanced glycation end products is associated with obesity and metabolic syndrome in adolescents. Int J Endocrinol. 2014;2014:657607.

Article  PubMed  PubMed Central  Google Scholar 

Liao Y, Huang R, Sun Y, Yue J, Zheng J, Wang L, et al. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients. Reprod Biol Endocrinol. 2017;15(1):9.

Article  PubMed  PubMed Central  Google Scholar 

Wong MCS, Huang J, Wang J, Chan PSF, Lok V, Chen X, et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. European Journal of Epidemiology. 2020;35(7):673–83.

Article  PubMed  PubMed Central  Google Scholar 

Ramachandran A, Chamukuttan S, Shetty SA, Arun N, Susairaj P. Obesity in Asia – is it different from rest of the world. Diabetes/Metabolism Research and Reviews. 2012;28(s2):47–51.

Article  PubMed  Google Scholar 

Ng SM, Su X. Prevalence and correlates of metabolic syndrome in Hong Kong Chinese adults-a random community sample study. Psychol Health Med. 2018;23(4):485–95.

Article  PubMed  Google Scholar 

Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.

Article  CAS  PubMed  Google Scholar 

Bettiga A, Fiorio F, Di Marco F, Trevisani F, Romani A, Porrini E, et al. The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): an overview of its impact on obesity and early progression of Renal Pathology. Nutrients. 2019;11(8).